Related Experiment Videos
Recurrent cervical cancer: detection and prognosis
Annette Duyn1, Marion Van Eijkeren, Gemma Kenter
1Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, The Netherlands.
Acta Obstetricia Et Gynecologica Scandinavica
|April 16, 2002
Summary
Recurrent cervical cancer is rarely detected during routine follow-up, with most cases identified by patient symptoms. The disease-free interval (DFI) is a key prognostic factor for survival in recurrent cervical cancer patients.
Area of Science:
- Gynecologic Oncology
- Clinical Cancer Research
- Epidemiology of Cancer Recurrence
Background:
- Cervical cancer recurrences are infrequently identified during standard follow-up protocols.
- Effective detection and prognostic factors for recurrent cervical cancer require further investigation.
Purpose of the Study:
- To determine the detection rate of cervical cancer recurrence during routine follow-up.
- To identify diagnostic tools aiding in the detection of recurrent disease.
- To ascertain prognostic factors for survival in patients with recurrent cervical cancer stage IB-IVA.
Main Methods:
- Retrospective analysis of clinical records from 277 patients treated for cervical cancer (stage IB-IVA).
- Data collected on primary tumor characteristics, recurrent disease, and follow-up procedures.
- Inclusion criteria: complete remission of at least 3 months post-primary treatment.
Main Results:
- 17% (47/277) of patients developed recurrent disease.
- Recurrence detection occurred most frequently via self-referral (45%) versus routine follow-up (32%).
- Symptom presentation (87%) was the primary indicator for recurrence diagnosis; disease-free interval (DFI) showed prognostic significance.
Conclusions:
- Routine follow-up detected only 32% of cervical cancer recurrences.
- The majority of recurrent cervical cancer cases were identified through patient-reported symptoms.
- Disease-free interval (DFI) emerged as a significant prognostic factor for survival in recurrent cervical cancer.